Salmon Calcitonin
Calcitonin for bone loss and hypercalcemia. Potent osteoclast inhibitor reducing bone resorption, serum calcium, and Paget’s disease activity with rapid onset of action.
Salmon Calcitonin is a polypeptide hormone derived from salmon ultimobranchial glands, consisting of 32 amino acids with a disulfide bridge between Cys1 and Cys7. It is approximately 30-50 times more potent than human calcitonin in inhibiting osteoclast-mediated bone resorption. It is indicated for the treatment of osteoporosis, Paget’s disease of bone, hypercalcemia, and bone pain, and is widely used in both injectable and nasal spray formulations.
| Parameter | Specification |
| CAS | 47931-85-1 |
| Molecular Formula | C₁₄₅H₂₄₀N₄₄O₄₈S₂ |
| Molecular Weight | 3431.85 g/mol |
| Category | Bone Health |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Osteoporosis, hypercalcemia, Paget’s disease, bone pain |
| CAS | 47931-85-1 |
|---|---|
| Applications |
Related products
-
Pramlintide
CAS: 196078-30-5 -
GLP-1 (7-37)
CAS: 106612-94-6Applications: Diabetes Research, GLP-1 Analog Development, metabolic syndrome -
Exenatide Acetate
CAS: 141732-76-5Applications: GLP-1, obesity management, Type 2 diabetes -
Lixisenatide
CAS: 320367-13-3Applications: postprandial glucose control, Short-acting GLP-1, Type 2 diabetes